MEDIA

Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

23 May 2022

Revance to Participate in the William Blair 42nd Annual Growth Stock Conference

10 May 2022

Revance Reports First Quarter 2022 Financial Results, Provides Corporate Update

03 May 2022

Revance to Release First Quarter Financial Results on Tuesday, May 10, 2022

02 May 2022

The Best Skincare Products and Treatments of 2022

25 April 2022

Facial Fillers 101: A Complete Guide to Injectable Fillers

22 April 2022

FDA Accepts Revance’s BLA Resubmission for DaxibotulinumtoxinA